| 产品名称 | Erlotinib |
|---|---|
| 英文名称 | Erlotinib |
| 别名 | R 1415;埃罗替尼 |
| 英文别名 | NSC 718781;OSI-744;R-1415;OSI744;OSI 744;R1415;R 1415;N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; Tarceva |
| 应用 | A tyrosine kinase inhibitor |
| 规格或纯度 | ≥98% |
| 运输条件 | 超低温冰袋运输 |
| 生化机理 | Erlotinib hydrochloride (trade name Tarceva;NSC 718781; OSI 744; R 1415 ) is a drμg used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. Erlotinib hydrochloride (trade name Tarceva;NSC 718781; OSI 744; R 1415 ) is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche. |
Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor
Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.
A tyrosine kinase inhibitor
| CAS编号 | 183321-74-6 |
|---|---|
| 折光率 | 1.62 |
| 熔点 | 167-180°C |
| 溶解性 | DMSO |
| 储存温度 | -20°C储存 |
| 分子量 | 393.44 |
| 分子式 | C22H23N3O4 |
| 品牌 | 阿拉丁 |
| PubChem CID | 176870 |